Eric Benner Email

Co-Founder, Chief Scientific Officer . Tellus Therapeutics

Current Roles

Employees:
11
Revenue:
$852.5k
About
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. Tellus' lead candidate, TT-20, induces regeneration of myelin-producing oligodendrocytes, reverses white matter injury in an animal models of perinatal brain injury and multiple sclerosis and is pursuing a novel regulatory path to evaluate safety and efficacy in newborns with brain injury.
Tellus Therapeutics Address
517 Summit Trail Drive, Research Triangle Par
Hillsborough, NC
Tellus Therapeutics Email

Past Companies

Tellus ThereCo-Founder, Chief Scientific Officer
Duke University Medical CenterNeonatologist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.